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Background: Striae gravidarum is a physiological skin change that many pregnant women experience during
pregnancy. The striae are often accompanied by a reddish purple color during pregnancy, and then lose
pigmentation and become atrophic in the long term after pregnancy. Striae gravidarum seems to be undesirable to
many pregnant women. However, the impact of striae gravidarum on pregnant women who experience it has not
been clarified. The aim of this study was to evaluate the impact of striae gravidarum on the generic and
dermatology-specific quality of life (QOL) of pregnant women.
Methods: A cross-sectional study was conducted at three private clinics in a typical urban area in Japan. We
recruited 447 pregnant women at 36 weeks of gestation; One hundred and ninety-nine pregnant women at 36
weeks of gestation participated in the study and 179, consisting of 94 primiparae and 85 multiparae, were analyzed.
We used and assessed Davey’s score for striae gravidarum, World Health Organization Quality of Life assessment
questionnaire for generic QOL, and Skindex-29 for dermatology-specific QOL.
Results: The prevalence of striae gravidarum was 39.1% (27.7% in primiparae, and 51.8% in multiparae). Although
there were no differences in generic QOL scores between the presence and absence of striae gravidarum and with
their severity, the whole group of pregnant women and the multiparae group showed significant differences in
scores on emotion of Skindex-29 between the presence and absence of striae gravidarum (p= 0.012 and p= 0.011).
Pregnant women with severe striae gravidarum showed significantly higher scores on emotion of Skindex-29
compared with those with absent or mild striae gravidarum (p< 0.001 and p= 0.005).
Conclusions: There was no difference in generic QOL of pregnant women between the presence and absence of
striae gravidarum, although the occurrence and severity of striae gravidarum influenced their dermatology-specific
QOL. Multiparae women were especially impaired by striae gravidarum and it is considered important to prevent or
reduce the severity of striae gravidarum of the multiparae group.
Keywords: Striae gravidarum, Quality of life, Japanese pregnant womenBackground
Striae gravidarum is a physiological skin change that
many pregnant women experience during pregnancy
[1,2]. They are linear lesions frequently found on the ab-
domen, breasts, buttocks and thighs. They are often ac-
companied by a reddish purple color during pregnancy,* Correspondence: yamaguchi@hs.med.kyoto-u.ac.jp
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distribution, and reproduction in any mediumand then lose pigmentation and become atrophic in the
long term after pregnancy. As striae gravidarum are
regarded as a physiological change, medical professionals
do not pay much attention to pregnant women with this
condition, and thus few data on the prevalence and
QOL of women having striae gravidarum are available.
However, striae gravidarum seems to be undesirable to
many pregnant women.
Striae gravidarum do not pose a health risk. However,
they are often symptomatic, causing itching and discom-
fort as well as psychological distress in pregnant womentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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on the abdomen, are a cause of cosmetic concern for
pregnant or postpartum women, who often seek various
expensive and painful treatments even if such treatments
are not effective [1,2]. It thus seems to be important to
objectively evaluate the influence of striae gravidarum
on the QOL of pregnant woman and postpartum
women.
Since a QOL evaluation is regarded as important in
those dermatological conditions that do not threaten life,
generic and dermatology-specific QOL evaluations are
combined for research in dermatology. According to the
review described by Both [3], the SF-36 and WHOQOL-
BREF as generic scales, and the Skindex-29 and Skindex-
17 as dermatology-specific scales are recommended for
evaluating the QOL of patients with dermatological con-
ditions. In the present study, Davey’s scoring [4] was used
to evaluate the abdominal striae gravidarum of Japanese
pregnant women. Also, the QOL of pregnant women was
examined using WHOQOL-BREF and Skindex-29. We
then determined the association between the severity of
striae gravidarum and QOL. The aim of this study was to
evaluate the impact of striae gravidarum on the generic




A cross-sectional study design was adopted using a self-
administered questionnaire. The study was performed at
three private clinics in Aichi Prefecture between October
2010 and January 2011. Aichi Prefecture is a typical
urban area of central Japan. The Ethical Committee ofTable 1 Clinical characteristics
Total
Age 30.8 ± 4.2 (n = 179)
(21–42)
Height 157.9 ± 5.7 (n = 179)
(145.0-178.0)
Weight before pregnancy 52.4 ± 8.3 (n = 178)
(38.0-90.0)
Weight at delivery 62.2 ± 8.5 (n = 177)
(42.7-96.8)
Weight gain during pregnancy 9.9 ± 3.1 (n = 176)
(1.0-22.8)
BMI before pregnancy 21.0 ± 3.2 (N = 178)
(16.0-38.0)
BMI at delivery 25.0 ± 3.1 (N = 177)
(17.3-40.0)
( − ) indicates in range.
Date were analyzed by unpaired t-test.Osaka University Medical School approved the study.
The anonymity of the participants was preserved.
Participants and procedure
We recruited all pregnant women who visited for an
antenatal examination at 36 weeks of gestation during
the study period, excluding twin and threatened prema-
ture cases. Pregnant women were given an explanation
of the content of the study by a document and orally
during waiting for prenatal examination by researchers.
Written informed consent regarding study cooperation
was obtained from all participants.
Of the 447 pregnant women recruited, 199 (44.5%)
agreed to participate in the study and provided written
informed consent. The women were surveyed using the
Skindex-29 and WHOQOL-BREF questionnaires. Data
regarding age at delivery, maternal height, maternal
weight at delivery and maternal weight before pregnancy
were collected from their medical charts. After collecting
the questionnaires, the striae gravidarum on the abdo-
men were assessed by three researchers (one in each
clinic) according to Davey’s method.
Of the 199 participants, 20 were excluded from the
study due to incomplete questionnaires in 17, no medical
records in 2, and no record of Davey’s score in 1. The
clinical characteristics of the 179 pregnant women, con-
sisting of 94 primiparae and 85 multiparae, participating
in this study, are summarized in Table 1. Recently, striae
gravidarum was significantly more common in women
who had been born prematurely than in women who had
been born at term [5]. Then, pregnant women delivered
after 37 weeks of gestation were used as subjects of the
study.Primiparae Multiparae p-value
29.9 ± 4.0 (n = 94) 31.8 ± 4.2 (n = 85) 0.002
(23–40) (21–42)
158.4 ± 5.9 (n = 94) 157.3 ± 5.2 (n = 85) 0.188
(146.0-178.0) (145.0-170.0)
51.3 ± 7.4 (n = 94) 53.6 ± 9.1 (n = 84) 0.054
(40.0-80.0) (38.0-90.0)
61.5 ± 7.8 (n = 93) 63.1 ± 9.1 (n = 84) 0.208
(47.2-92.8) (42.7-96.8)
10.2 ± 3.1 (n = 93) 9.5 ± 3.2 (n = 83) 0.107
(1.0-22.8) (1.7-16.1)
20.4 ± 2.6 (n = 94) 21.7 ± 3.6 (n = 84) 0.008
(16.0-30.4) (16.5-38.0)
24.5 ± 2.6 (n = 93) 25.5 ± 3.5 (n = 84) 0.031
(18.4-32.3) (17.3-40.0)
Table 2 Striae gravidarum assessed by Davey’s scoring







Primiparae (%) 94 68 (72.3) 22 (23.4) 4 (4.3) 0.000
Multiparae (%) 85 41 (48.2) 22 (25.9) 22 (25.9)
Total (%) 179 109 (60.8) 44 (24.4) 26 (14.8)
Data were analyzed using chi-squared test.
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The WHOQOL-BREF was developed collaboratively in
several countries including Japan [6,7]. It assesses a gen-
eric QOL that is applicable to people living in different
cultures. The Japanese version has been developed with
good reliability and validity [7,8].
The WHOQOL-BREF is a 26 item self-administered
questionnaire and consists of 24 items in four domains:
physical health, psychological, social relationships, envir-
onment, and two ‘benchmark’ items about general well-
being. The participants selected responses ranging from
1 (none) to 5 (extremely). Scores were calculated accord-
ing to the guidelines for the WHOQOL-BREF. Higher
scores indicate higher QOL.
Skindex-29
This questionnaire was developed by Chren et al. in 1997
and consists of 30 items forming three scales: emotion in
10 items, symptoms in 7 items, and functioning in 12
items (item 18 is not included in scoring the instrument)
[9]. The emotions scale measures the psychological effects
of the disease, such as anxiety of being seriously ill, anxiety
of getting a scar, anxiety of getting worse, depression,
ashamedness, embarrassment, anger, frustration, humili-
ation, or annoyance. The symptoms scale measures the
physical burden of the disease, such as pain, burning/
stinging, itching, fluid accumulation-induced anxiety, irri-
tation, sensitiveness, or bleeding. The functioning subscale
focuses on the changes in daily life, such as sleep, work/
hobby, social life, how close one can be with loved ones,
desire to be with people, affection, staying at home, a
problem for the people one loves, interference with sex
life, doing things by oneself, interaction with others, or
tiredness. The participants can select responses ranging
from 0 (never) to 4 (all the time). All responses were
transformed into linear scale scores, which varied from 0
(no effect) to 100 (maximum effect). The three subscales
score separately and a higher score indicates a lower
QOL. The scale has been translated into German [10],
Italian [11], Spanish [12] and Turkish [13]. The Japanese
version of Skindex-29 was made by Fukuhara [14] and suf-
ficient reliability was demonstrated with Cronbach’s alpha
coefficiencies of 0.94 in emotion, 0.81 in symptoms, and
0.94 in functioning. The reproducibilities were r = 0.93,
0.91, and 0.91 in each subscale.
Davey’s score
The abdomen was divided into quadrants using the mid-
line and horizontal line through the umbilicus. Each
quadrant was scored 0 (=clear skin), 1 (=moderate num-
ber of striae) or 2 (=many striae). Total sum scores ran-
ged from 0 to 8. The severity of striae gravidarum was
divided into three categories, 0 (absent), 1 to 2 (mild),
and 3 to 8 (severe), as assessed by Davey’s score.For the standardization of scoring for objectivity, a re-
searcher (Yamaguchi) visited every clinic and educated
the researchers to learn Davey’s score using the drawings
in the manuscript written by Buchanan, et al. [15]. Dur-
ing the research, the rate of appearance of striae gravi-
darum was periodically compared among clinics.
Statistical analysis
The data analysis was performed with IBM SPSS Statis-
tics 19. The unpaired t-test was applied for statistical
analyses of subject profiles. The chi-squared test was
used to examine the relationship between Davey’s scores
and parity. The QOL scores on the Skindex-29 and
WHOQOL-BREF were analyzed using the Mann–Whitney
test and the Kruskal-Wallis test followed by the Mann–
Whitney test with Bonferroni correction. The significance
level was set at 5%.
Results
Sample characteristics
The clinical characteristics of the 179 pregnant women,
consisting of 94 primiparae and 85 multiparae participat-
ing in this study, are summarized in Table 1.
The severity of striae gravidarum was divided into
three categories, 0 (absent), 1 to 2 (mild), and 3 to 8 (se-
vere), as assessed by Davey’s score. The prevalences of
striae gravidarum were 39.1% (70/179), 27.7% (26/94)
and 51.8% (44/85) in the whole group of pregnant
women, primiparae and multiparae, respectively (Table 2).
The severity of striae gravidarum depended on parity
(p < 0.001), and severe cases appeared in 4.3% of prim-
iparae and 25.9% of multiparae.
The QOL of pregnant women with and without striae
gravidarum was evaluated (Table 3). There was no differ-
ence in WHOQOL-BREF scores between the presence and
absence of striae gravidarum in primiparae and multiparae.
Although primiparae did not show significant differences
in scores on the three subcategories of Skindex-29 between
the presence and absence of striae gravidarum, multiparae
showed a significant difference in scores of emotion on
Skindex-29 between them. In the whole group, scores of
emotion on Skindex-29 among pregnant women with
striae gravidarum were significantly higher than those
without striae gravidarum.
Table 3 Skindex-29 and WHOQOL-BREF scores of
pregnant women with and without striae gravidum
Striae gravidarum
Total Absence Presence p-value
Total n 179 109 70
Skindex 29
Emotion 2.5 2.5 5.0 0.012
(0.0-10.0) (0.0-7.5) (0.0-18.1)
Symptoms 14.3 14.3 17.9 0.163
(10.7-25.0) (10.7-21.4) (10.7-28.6)
Functioning 0.0 0.0 0.0 0.413
(0.0-0.0) (0.0-0.0) (0.0-0.0)
WHOQOL-BREF 3.5 3.5 3.6 0.342
(3.2-3.8) (3.2-3.9) (3.2-3.8)
Primiparae n 94 68 26
Skindex 29
Emotion 2.5 2.5 6.3 0.173
(0.0-10.0) (0.0-7.5) (0.0-20.6)
Symptoms 17.9 14.3 19.6 0.307
(10.7-25.0) (10.7-24.0) (10.7-28.6)
Functioning 0.0 0.0 0.0 0.592
(0.0-0.0) (0.0-0.0) (0.0-0.0)
WHOQOL-BREF 3.5 3.6 3.5 0.703
(3.3-3.8) (3.3-3.8) (3.3-3.9)
Multiparae n 85 41 44
Skindex 29
Emotion 2.5 0.0 5.0 0.011
(0.0-8.8) (0.0-5.0) (0.0-16.9)
Symptoms 14.3 14.3 16.1 0.193
(10.7-25.0) (10.7-19.6) (10.7-25.0)
Functioning 0.0 0.0 0.0 0.758
(0.0-0.0) (0.0-0.0) (0.0-0.0)
WHOQOL-BREF 3.5 3.5 3.6 0.526
(3.2-3.8) (3.2-4.0) (3.2-3.8)
Data were analyzed by Mann–Whitney U test.
( − ) indicates in interquartile range (IQR).
Table 4 Skindex-29 scores of pregnant women with striae
gravidum by Davey’s scoring







n 179 109 44 26 0.000
Emotion 2.5 2.51) 2.52) 8.81)2) 0.000
Total (%) 179 109 (60.8) 44 (24.4) 26 (14.8)
(0.0-10.0) (0.0-7.5) (0.0-14.4) (2.5-25.0)
Symptoms 14.3 14.3 14.3 21.4 0.163
(10.7-25.0) (10.7-21.4) (10.7-25.0) (13.4-28.6)
Functioning 0.0 0.03) 0.04) 0.03)4) 0.013
(0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-4.2)
WHOQOL-BREF 3.5 3.5 3.6 3.4 3.4
(3.2-3.8) (3.2-3.9) (3.3-3.8) (3.2-3.8)
1) P= 0.000 2) P = 0.005 3) P= 0.012 4) P= 0.009.
Date were analyzed by Kruskal-Wallis test followed by Mann–Whitney test with
Bonferroni correction.
( − ) indicates in interquartile range (IQR).
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darum was examined (Table 4). There were no differ-
ences in WHOQOL-BREF scores among the three
subgroups. However, pregnant women with severe striae
gravidarum showed significantly higher scores in emo-
tion and functioning on Skindex-29 compared with
those without striae gravidarum and those with mild
striae gravidarum.
Discussion
An assessment system for striae gravidarum has not been
established. Generally applicable methods to estimate thestriae gravidarum were reported by Davey [4] and Atwal
et al. [16], and original rating systems are also found in
some other studies. In Davey’s method, the striae gravi-
darum spreading through the whole abdomen are evalu-
ated, and this method is widely used. An evaluation of
color of the striae gravidarum as well as their presence
features in Atwal’s method which was reported recently.
As three researchers were to evaluate striae gravidarum
independently in this study, the assessment system
needed to be simple and easy to perform in order to re-
duce variations in measurement among researchers. We
thus adopted Davey’s method in the present study. As a
result, the prevalences of striae gravidarum in the three
clinics were 39.4%, 36.7% and 42.0%, respectively, suggest-
ing that Davey’s method is a stable rating system when
multiple researchers perform it.
The prevalence of striae gravidarum among Japanese
women was 39.1% (27.7% for primiparae and 51.8% for
multiparae) in this study. This is a lower rate than in
previous reports. The occurrence rates of striae gravi-
darum among primiparae in the UK were 48.6% in
Davey's first report in 1970 [4] and 63% in 2001 [17]. Al-
though some studies used Davey 's method, it is difficult
to compare the prevalence of striae gravidarum because
of a lack of data about parity [18,19] or unclear descrip-
tions of the assessment procedures used [20].
Striae gravidarum are described in textbooks, without
any evidence, as a serious concern during pregnancy
[21]. However, there are no studies of the influence of
striae gravidarum on the QOL of pregnant women be-
cause the striae gravidarum have conventionally been
considered a minor medical concern. Once striae gravi-
darum appear during pregnancy, they remain after
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abnormal skin condition, the influence of striae gravi-
darum on women’s dermatology-specific QOL was also
evaluated in the study.
In counseling for skin disease, the QOL evaluation is
beneficial as information about the interests and con-
cerns of subjects can be obtained [22]. It is desirable for
a QOL evaluation of patients with skin disease to esti-
mate the generic and dermatology-specific QOL at the
same time. The combination of a generic QOL scale
such as SF-36 or WHOQOL-100 and a dermatology-
specific QOL scale such as Skindex-29 or Skindex-17 is
most often used in such clinical studies [22]. Each scale
has unique characteristics. An item about sexuality is
not included in SF-36, whereas it is included in WHO-
QOL-100. We thought that the item about sexuality
could be important in assessing the QOL of healthy
pregnant women. Furthermore, we selected WHOQOL-
BREF, i.e., a brief version of WHOQOL-100, in consider-
ation of the time required for responding.
As for the score of WHOQOL-BREF, there were no
significant differences according to the presence (median
3.6) or absence (median 3.5) of striae gravidarum in this
study. The mean scores of WHOQOL-BREF were
3.5 ± 0.5 in pregnant women with striae gravidarum and
3.6 ± 0.4 in those without them. In the manual of the
WHOQOL-BREF Japanese version, the general scores of
WHOQOL-BREF are 3.3 ± 0.5 for 20–29 year-old and
3.2 ± 0.4 for 30–39 year-old Japanese women, suggesting
that the participants’ generic QOL was not affected by
the presence of striae gravidarum. However, scores of
emotion in the whole group of pregnant women and
multiparae were significantly increased by the occur-
rence of striae gravidarum, whereas those in primiparae
were not (Table 3). As described in Tables 2 and 4, se-
vere striae gravidarum appeared more frequently in mul-
tiparae than in primiparae and impaired emotion in the
dermatology-specific QOL significantly more than mild
striae gravidarum did. The median score of emotion in
pregnant women with striae gravidarum was 5.0 and the
mean score was 10.7. Mean scores of emotion reported
elsewhere were 12.3 in patients with ectodermal dyspla-
sia [23], 29.5 in vitiligo patients [24], and 48 in patients
with cutaneous lupus erythematosus [25]. In free
answers from the participants, pregnant women stated
their reconciliation with this unpleasant state e.g., "I can-
not help striae gravidarum because they are naturally
caused by the pregnancy." or "Although I want to pre-
vent the striae gravidarum if possible, I have given up on
preventing the striae gravidarum because I can obtain
greater things from pregnancy than striae gravidarum”.
These results indicate that the striae gravidarum moder-
ately affected emotion in the dermatology-specific QOL,
similar to other skin conditions. It is therefore certainthat striae gravidarum affect the emotions of pregnant
women. In severe cases of acne [26] and vitiligo [24],
significantly elevated scores of emotion on Skindex-29
were reported, which was similar to our results, suggest-
ing that severity is also important when assessing the
impact on emotion.
In scores of symptoms, there were no significant differ-
ences between the presence and absence of striae gravi-
darum, and the mean score was 18.6 in the whole group
of pregnant women. The mean scores of symptoms were
reported to be 16.3 and 25.3 in groups containing males
and females with vitiligo [24] and ectodermal dysplasia
[23]. Regardless of the presence or absence of striae gravi-
darum, pregnant women possibly suffer from such der-
matological symptoms at similar levels to other skin
diseases. As a result, most pregnant women might seek
prophylaxis for striae gravidarum. In the study, 77.7% of
pregnant women used ointment or lotion, expecting a
prophylactic effect against striae gravidarum.
Scores of functioning in severe cases were significantly
higher than mild cases and cases without striae gravi-
darum. However, the mean score (1.4) in the whole
group of pregnant women was very low as compared
with other skin diseases and is equivalent to the mean
score of 4 reported in controls [26], suggesting that
striae gravidarum are unlikely to affect the functioning
of pregnant women. Striae gravidarum mainly appear on
the abdomen, which can be covered with clothes and is
rarely exposed to the public eye, unlike some other skin
diseases, so it might not affect functioning. Skindex-17
consists of two subcategories; emotion and symptoms of
Skindex-29, and might be appropriate to examine the in-
fluence of striae gravidarum on QOL.
Limitations
This is the first trial to evaluate the QOL of pregnant
women with striae gravidarum, and so no comparison of
results among studies or calculation of an adequate sam-
ple size could be conducted. The sample size was based
on those in the previous studies which used Skindex-29
[23-26].
The psychological influence of striae gravidarum on preg-
nant women seems to vary with race. Such psychological
burdens are associated with QOL or several preventive
behaviors. In this study, 77.7% (138/179) of Japanese preg-
nant women used skin lotions or skin creams in order to
prevent striae gravidarum. As the relationship between
QOL and preventive behavior by pregnant women with
striae gravidarum in several countries is not obvious, such
examinations might be needed in future studies.
Conclusions
A point to be emphasized is the fact that striae gravi-
darum have a moderate affect on QOL in Japanese
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eases, although striae gravidarum has been considered as a
minor complaint. The occurrence of striae gravidarum
influences the QOL of pregnant women, and their severity
is important. In this study, 22 of 26 severe cases were mul-
tiparae and the emotion aspects of dermatology-specific
QOL in multiparae were impaired by striae gravidarum.
Judging from the perspective of the QOL of pregnant
women, it is considered important to prevent severe striae
gravidarum of multiparae, because the damage to QOL by
the striae gravidarum could be relieved by keeping their
severity to a mild level.
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